| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.8 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |